|
US3102116A
(en)
|
|
1963-08-27 |
|
Process for the purification of y-chloeo- |
|
US3109843A
(en)
|
|
1963-11-05 |
|
Process for preparing |
|
BE557575A
(cg-RX-API-DMAC7.html)
*
|
1956-05-16 |
|
|
|
|
US3371085A
(en)
*
|
1959-12-10 |
1968-02-27 |
Hoffmann La Roche |
5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
|
|
US3136815A
(en)
*
|
1959-12-10 |
1964-06-09 |
Hoffmann La Roche |
Amino substituted benzophenone oximes and derivatives thereof
|
|
US3340253A
(en)
*
|
1962-11-28 |
1967-09-05 |
Hoffmann La Roche |
Preparation of certain benzodiazepine compounds
|
|
US3243427A
(en)
*
|
1962-06-21 |
1966-03-29 |
Hoffmann La Roche |
Certain 5-phenyl-1, 2-dihydro (or 1, 2, 4, 5-tetrahydro)-3h-1, 4,-benzodiazepine compounds and their production
|
|
US3374225A
(en)
*
|
1963-03-28 |
1968-03-19 |
Hoffmann La Roche |
Aminobenzodiazepine compounds and methods
|
|
NL298071A
(cg-RX-API-DMAC7.html)
*
|
1963-06-04 |
|
|
|
|
GB1052144A
(cg-RX-API-DMAC7.html)
*
|
1964-02-11 |
|
|
|
|
US3567710A
(en)
*
|
1968-06-03 |
1971-03-02 |
Hoffmann La Roche |
Process for the preparation of 1,3-dihydro-2h-1,4-benzodiazepin-2-ones
|
|
US3547828A
(en)
|
1968-09-03 |
1970-12-15 |
Rohm & Haas |
Alkyl oligosaccharides and their mixtures with alkyl glucosides and alkanols
|
|
US3609145A
(en)
*
|
1969-01-10 |
1971-09-28 |
Upjohn Co |
1h-1,4-benzodiazepine-1-sulfonamides
|
|
US3987052A
(en)
*
|
1969-03-17 |
1976-10-19 |
The Upjohn Company |
6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
|
|
US3722371A
(en)
*
|
1970-03-12 |
1973-03-27 |
Pneumo Dynamics Corp |
High ratio linkage mechanism
|
|
GB1355998A
(en)
|
1970-09-30 |
1974-06-12 |
Unilever Ltd |
Builders for detergent compositions
|
|
US3949072A
(en)
|
1971-03-11 |
1976-04-06 |
Tenta Louis T |
Topical composition for treatment of seborrheic keratosis
|
|
US4280957A
(en)
*
|
1974-09-11 |
1981-07-28 |
Hoffmann-La Roche Inc. |
Imidazodiazepines and processes therefor
|
|
US4130709A
(en)
|
1977-12-08 |
1978-12-19 |
Eli Lilly And Company |
Pleuromutilin glycoside derivatives
|
|
JPS57128634A
(en)
*
|
1981-02-03 |
1982-08-10 |
Eisai Co Ltd |
Elastase-containing compound increasing absorption
|
|
US4440675A
(en)
|
1981-08-18 |
1984-04-03 |
Meloy Laboratories, Inc. |
Human immune interferon
|
|
US4608278A
(en)
*
|
1983-06-22 |
1986-08-26 |
The Ohio State University Research Foundation |
Small particule formation and encapsulation
|
|
AU570998B2
(en)
|
1983-09-07 |
1988-03-31 |
Takeda Chemical Industries Ltd. |
Topical steroid compositions for acne
|
|
JPS60208911A
(ja)
|
1984-03-28 |
1985-10-21 |
Green Cross Corp:The |
ジアゼパム直腸投与製剤
|
|
US4826689A
(en)
*
|
1984-05-21 |
1989-05-02 |
University Of Rochester |
Method for making uniformly sized particles from water-insoluble organic compounds
|
|
JPS61267528A
(ja)
|
1984-11-26 |
1986-11-27 |
Yamanouchi Pharmaceut Co Ltd |
吸収促進剤を含有するカルシトニン経鼻剤
|
|
DE3444958A1
(de)
*
|
1984-12-10 |
1986-06-12 |
Henkel KGaA, 4000 Düsseldorf |
Verwendung von alkylglykosiden als potenzierungsmittel in antiseptischen mitteln sowie desinfektions- und reinigungsmittel mit verstaerkter bakterizider wirkung
|
|
DK17685D0
(da)
*
|
1985-01-14 |
1985-01-14 |
Hans Goeran Magnusson |
Glycosidderivater
|
|
US5192528A
(en)
|
1985-05-22 |
1993-03-09 |
Liposome Technology, Inc. |
Corticosteroid inhalation treatment method
|
|
CA1338736C
(fr)
|
1986-12-05 |
1996-11-26 |
Roger Baurain |
Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
|
|
FR2608988B1
(fr)
*
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
|
US5550220A
(en)
*
|
1987-05-13 |
1996-08-27 |
Curtice-Burns, Inc. |
Alkyl glycoside fatty acid polyester fat substitute food compositions and process to produce the same
|
|
US4921838A
(en)
*
|
1987-06-16 |
1990-05-01 |
Trustees Of Boston University |
Angiogenic and blood perfusion inducing properties of amphiphilic compounds
|
|
JPH01151528A
(ja)
|
1987-12-08 |
1989-06-14 |
Taiho Yakuhin Kogyo Kk |
経粘膜吸収促進剤
|
|
WO1990005535A1
(fr)
|
1988-11-14 |
1990-05-31 |
Otsuka Pharmaceutical Co., Ltd. |
Preparation a base d'interferon pour administration nasale
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
US5705363A
(en)
*
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
|
US5033087A
(en)
|
1989-03-14 |
1991-07-16 |
International Business Machines Corp. |
Method and apparatus for the automatic determination of phonological rules as for a continuous speech recognition system
|
|
US5182258A
(en)
*
|
1989-03-20 |
1993-01-26 |
Orbon Corporation |
Systemic delivery of polypeptides through the eye
|
|
US5122187A
(en)
|
1989-06-22 |
1992-06-16 |
Xerox Corporation |
Hot melt ink compositions
|
|
FR2651680B1
(fr)
*
|
1989-09-14 |
1991-12-27 |
Medgenix Group Sa |
Nouveau procede de preparation de microparticules lipidiques.
|
|
US6482516B1
(en)
|
1993-07-20 |
2002-11-19 |
Banner Pharmacaps, Inc. |
Enrobed tablet
|
|
US5198420A
(en)
|
1989-10-02 |
1993-03-30 |
The General Hospital Corporation |
Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome
|
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
|
US5369095A
(en)
|
1990-02-14 |
1994-11-29 |
Alcon Laboratories, Inc. |
Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
|
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
ES2117642T3
(es)
|
1990-05-10 |
1998-08-16 |
Bechgaard Int Res |
Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
|
|
US5252318A
(en)
|
1990-06-15 |
1993-10-12 |
Allergan, Inc. |
Reversible gelation compositions and methods of use
|
|
CA2065265A1
(en)
|
1990-06-27 |
1991-12-28 |
Tadao Shoji |
Alkylated oligosaccharides and acetyl derivatives of the same
|
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
EP0513813B1
(en)
*
|
1991-05-16 |
1996-10-09 |
Kao Corporation |
Alkyl glycoside aqueous solution stable to microbial activity
|
|
US5317010A
(en)
*
|
1991-10-10 |
1994-05-31 |
Peter K. T. Pang |
Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
|
|
US5236707A
(en)
*
|
1991-11-08 |
1993-08-17 |
Dallas Biotherapeutics, Inc. |
Stabilization of human interferon
|
|
US5457100A
(en)
|
1991-12-02 |
1995-10-10 |
Daniel; David G. |
Method for treatment of recurrent paroxysmal neuropsychiatric
|
|
US5308531A
(en)
*
|
1992-08-31 |
1994-05-03 |
Henkel Corporation |
Pine-oil containing hard surface cleaning composition
|
|
WO1994005262A1
(en)
|
1992-09-10 |
1994-03-17 |
F.H. Faulding & Co. Limited |
Sustained release matrix composition
|
|
AU688283B2
(en)
*
|
1992-09-29 |
1998-03-12 |
Novartis Ag |
Pulmonary delivery of active fragments of parathyroid hormone
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US6090925A
(en)
*
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
WO1994020116A1
(en)
|
1993-03-10 |
1994-09-15 |
University Of Alabama Research Foundation |
Artificial primers for glycogen synthesis
|
|
US5661130A
(en)
*
|
1993-06-24 |
1997-08-26 |
The Uab Research Foundation |
Absorption enhancers for drug administration
|
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
|
US5510264A
(en)
|
1993-09-28 |
1996-04-23 |
Insight Biotech Inc. |
Antibodies which bind meningitis related homologous antigenic sequences
|
|
ES2171469T3
(es)
*
|
1993-10-21 |
2002-09-16 |
Hisamitsu Pharmaceutical Co |
Composicion administrada por via nasal y preparacion que la contiene.
|
|
GB9409778D0
(en)
*
|
1994-05-16 |
1994-07-06 |
Dumex Ltd As |
Compositions
|
|
US5556940A
(en)
|
1994-06-20 |
1996-09-17 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
US5955425A
(en)
*
|
1996-08-02 |
1999-09-21 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
SE9403846D0
(sv)
*
|
1994-11-09 |
1994-11-09 |
Univ Ohio State Res Found |
Small particle formation
|
|
SE9404196D0
(sv)
*
|
1994-12-02 |
1994-12-02 |
Astra Ab |
New antithrombotic formulation
|
|
SE9404468D0
(sv)
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
|
WO1996019198A1
(en)
*
|
1994-12-22 |
1996-06-27 |
Astra Aktiebolag |
Aerosol drug formulations
|
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
|
US5716642A
(en)
*
|
1995-01-10 |
1998-02-10 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
|
|
US5665331A
(en)
*
|
1995-01-10 |
1997-09-09 |
Nanosystems L.L.C. |
Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
|
|
US5662883A
(en)
*
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
|
US5560932A
(en)
|
1995-01-10 |
1996-10-01 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents
|
|
US5863949A
(en)
*
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
ATE198326T1
(de)
|
1995-04-20 |
2001-01-15 |
Pfizer |
Arylsulfonamido-substituierte hydroxamsäure derivate als inhibitoren von mmp und tnf
|
|
US20030118594A1
(en)
*
|
1995-06-07 |
2003-06-26 |
Bishwajit Nag |
Stable formulations of mhc-peptide complexes
|
|
US6143211A
(en)
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
|
US6852690B1
(en)
|
1995-08-22 |
2005-02-08 |
Amylin Pharmaceuticals, Inc. |
Method and composition for enhanced parenteral nutrition
|
|
WO1997014407A1
(en)
|
1995-10-17 |
1997-04-24 |
Research Triangle Pharmaceuticals |
Insoluble drug delivery
|
|
US5914332A
(en)
*
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
|
ES2183905T3
(es)
|
1995-12-20 |
2003-04-01 |
Hoffmann La Roche |
Inhibidores de metaloproteasa de matriz.
|
|
US6254854B1
(en)
*
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
EP0918773A1
(en)
|
1996-07-01 |
1999-06-02 |
PHARMACIA & UPJOHN COMPANY |
Process for the production of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo 1,5-a]benzodiazepine
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
IL127567A0
(en)
|
1996-07-18 |
1999-10-28 |
Pfizer |
Phosphinate based inhibitors of matrix metalloproteases
|
|
EA199900139A1
(ru)
|
1996-08-23 |
1999-08-26 |
Пфайзер, Инк. |
Производные арилсульфониламиногидроксамовой кислоты
|
|
AU5131998A
(en)
|
1997-01-06 |
1998-08-03 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
WO1998033768A1
(en)
|
1997-02-03 |
1998-08-06 |
Pfizer Products Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
NZ337065A
(en)
|
1997-02-05 |
2001-02-23 |
Jago Pharma Ag |
Medical aerosol formulations containing carbon dioxide, a hydrofluoroalkane, a cosolvent and a beta-mimetic / corticoid / anticholinergic / spasmolytic / analgesic agent
|
|
CA2279863A1
(en)
|
1997-02-07 |
1998-08-13 |
Pfizer Inc. |
N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
|
|
JP3710489B2
(ja)
|
1997-02-11 |
2005-10-26 |
ファイザー・インク |
アリールスルホニルヒドロキサム酸誘導体
|
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
|
US6245760B1
(en)
|
1997-05-28 |
2001-06-12 |
Aventis Pharmaceuticals Products, Inc |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
|
|
CA2294988C
(en)
*
|
1997-07-01 |
2015-11-24 |
Isis Pharmaceuticals Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
|
UA61963C2
(en)
|
1997-08-08 |
2003-12-15 |
Pfizer Prod Inc |
Aryloxysulfonylaminohydroxamic acid derivatives
|
|
US6165484A
(en)
|
1997-08-26 |
2000-12-26 |
Wake Forest University |
EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
|
|
US20050002867A1
(en)
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
MY120063A
(en)
|
1997-12-09 |
2005-08-30 |
Lilly Co Eli |
Stabilized teriparatide solutions
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
AU716724B2
(en)
|
1998-03-26 |
2000-03-02 |
Morton International, Inc. |
A latent mercaptan as a heat stabilizer
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
TWI223598B
(en)
*
|
1998-06-22 |
2004-11-11 |
Pfizer Ireland Pharmaceuticals |
An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
|
|
ITMI981528A1
(it)
|
1998-07-03 |
2000-01-03 |
Recordati Ind Chimica E Farma |
Formulazioni topiche di aciclovir
|
|
JP2002525311A
(ja)
|
1998-10-01 |
2002-08-13 |
エラン ファーマ インターナショナル，リミティド |
徐放性ナノ粒子組成物
|
|
US6608073B1
(en)
|
1998-10-14 |
2003-08-19 |
New Millennium Pharmaceutical Research, Inc. |
Intranasal codeine for the rapid suppression of cough and rapid relief of pain
|
|
EP1004578B1
(en)
|
1998-11-05 |
2004-02-25 |
Pfizer Products Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US6375986B1
(en)
*
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US20030087820A1
(en)
*
|
1999-01-14 |
2003-05-08 |
Young Andrew A. |
Novel exendin agonist formulations and methods of administration thereof
|
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6495498B2
(en)
|
1999-05-27 |
2002-12-17 |
Johnson & Johnson Consumer Companies, Inc. |
Detergent compositions with enhanced depositing, conditioning and softness capabilities
|
|
GB9912961D0
(en)
|
1999-06-03 |
1999-08-04 |
Pfizer Ltd |
Metalloprotease inhibitors
|
|
DE60038738T2
(de)
*
|
1999-07-26 |
2009-07-02 |
Sk Holdings Co., Ltd. |
Transnasale anticonvulsive zusammensetzungen
|
|
EP1206762B1
(en)
|
1999-08-26 |
2007-12-19 |
Automotive Systems Laboratory Inc. |
Magnetic sensor
|
|
US7144574B2
(en)
*
|
1999-08-27 |
2006-12-05 |
Maxygen Aps |
Interferon β variants and conjugates
|
|
US6316410B1
(en)
|
1999-09-22 |
2001-11-13 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
CN1303674A
(zh)
|
1999-12-02 |
2001-07-18 |
山东省医药工业研究所 |
阿普唑仑鼻喷剂
|
|
US20010043915A1
(en)
*
|
1999-12-09 |
2001-11-22 |
Chiron Corporation |
Method for administering a cytokine to the central nervous system and the lymphatic system
|
|
WO2001051030A1
(en)
*
|
2000-01-10 |
2001-07-19 |
Dura Pharmaceuticals, Inc. |
Pharmaceutical formulation and method for pulmonary and oral delivery
|
|
US20030118547A1
(en)
*
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
US7171965B2
(en)
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
|
US6610271B2
(en)
*
|
2000-05-10 |
2003-08-26 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of lorazepam
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
US6818741B2
(en)
|
2000-06-01 |
2004-11-16 |
Clf Medical Technology Acceleration Program, Inc. |
Alpha-fetoprotein peptides and uses therof
|
|
US20040147473A1
(en)
*
|
2000-11-10 |
2004-07-29 |
Warrell Raymond P. |
Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
|
|
US6595210B2
(en)
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
AU3664102A
(en)
*
|
2000-12-01 |
2002-06-11 |
Battelle Memorial Institute |
Method for stabilizing biomolecules in liquid formulations
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
GB0102902D0
(en)
|
2001-02-06 |
2001-03-21 |
Innovata Biomed Ltd |
Medicaments
|
|
US6551578B2
(en)
|
2001-02-15 |
2003-04-22 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
|
US20040176359A1
(en)
|
2001-02-20 |
2004-09-09 |
University Of Kentucky Research Foundation |
Intranasal Benzodiazepine compositions
|
|
US7316819B2
(en)
*
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
ATE494301T1
(de)
|
2001-06-02 |
2011-01-15 |
Clf Medical Technology Acceleration Program Inc |
Alpha-fetoprotein-peptide und ihre verwendung
|
|
EP1407785A4
(en)
|
2001-06-14 |
2009-12-02 |
Otsuka Pharma Co Ltd |
MEDICAL COMPOSITIONS
|
|
GB0116107D0
(en)
|
2001-06-30 |
2001-08-22 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical composition
|
|
DK1429731T3
(da)
|
2001-09-19 |
2007-05-14 |
Elan Pharma Int Ltd |
Nanopartikelformuleringer indeholdende insulin
|
|
DK1443912T3
(da)
*
|
2001-10-12 |
2008-01-21 |
Elan Pharma Int Ltd |
Sammensætninger med en kombination af umiddelbare og kontrollerede frisætningsegenskaber
|
|
US7220402B1
(en)
|
2001-11-20 |
2007-05-22 |
Ordway Research Institute, Inc. |
Alpha-fetoprotein peptides and uses for imaging
|
|
FR2834212B1
(fr)
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
|
|
JP4611641B2
(ja)
*
|
2002-03-20 |
2011-01-12 |
エラン ファーマ インターナショナル，リミティド |
Ｍａｐキナーゼ阻害剤のナノ粒子組成物
|
|
WO2003103701A1
(en)
|
2002-06-07 |
2003-12-18 |
Waratah Pharmaceuticals, Inc. |
Compositions and methods for treating diabetes
|
|
US20060106227A1
(en)
*
|
2002-06-13 |
2006-05-18 |
Dr Reddy's Laboratories Limited |
3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof
|
|
US6855332B2
(en)
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
|
EP1545474A1
(en)
*
|
2002-09-16 |
2005-06-29 |
Wyeth |
Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
|
|
US7166575B2
(en)
*
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
US20040248846A1
(en)
|
2003-04-22 |
2004-12-09 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of triptans
|
|
US20040258663A1
(en)
|
2003-05-08 |
2004-12-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of interferon alpha
|
|
GB0310919D0
(en)
*
|
2003-05-13 |
2003-06-18 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical compositions
|
|
US8008255B2
(en)
|
2003-05-30 |
2011-08-30 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
US7696147B2
(en)
|
2003-07-08 |
2010-04-13 |
L'oreal |
Perfume composition
|
|
AU2004266731A1
(en)
*
|
2003-08-21 |
2005-03-03 |
Transoral Pharmaceuticals, Inc. |
Compositions for delivering 5-HT agonists across the oral mucosa and methods of use thereof
|
|
CA2544627A1
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
ATE403670T1
(de)
*
|
2003-12-15 |
2008-08-15 |
Phasys Gmbh M |
Rückgefaltetes membranprotein in monodisperser form
|
|
US20060074025A1
(en)
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
|
GB0400804D0
(en)
|
2004-01-14 |
2004-02-18 |
Innoscience Technology Bv |
Pharmaceutical compositions
|
|
DE102004017934A1
(de)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
MXPA06012980A
(es)
|
2004-05-10 |
2007-06-12 |
Nastech Pharm Co |
Composiciones y metodos para el suministro mucosal mejorado de la hormona paratiroidea.
|
|
NZ551990A
(en)
*
|
2004-06-04 |
2011-01-28 |
Camurus Ab |
Liquid depot formulations
|
|
US20060046969A1
(en)
*
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Antibacterial compositions for drug administration
|
|
US8268791B2
(en)
*
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
|
EP1789075A4
(en)
|
2004-08-25 |
2009-07-01 |
Uab Research Foundation |
ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
|
|
US20140162965A1
(en)
|
2004-08-25 |
2014-06-12 |
Aegis Therapeutics, Inc. |
Compositions for oral drug administration
|
|
US8642564B2
(en)
*
|
2004-08-25 |
2014-02-04 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
US9114069B2
(en)
*
|
2004-08-25 |
2015-08-25 |
Aegis Therapeutics, Llc |
Antibacterial compositions for drug administration
|
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
|
US20110257096A1
(en)
|
2004-08-25 |
2011-10-20 |
Aegis Therapeutics, Inc. |
Compositions for drug administration
|
|
US20090047347A1
(en)
*
|
2005-07-29 |
2009-02-19 |
Aegis Therapeutics, Inc. |
Compositions for Drug Administration
|
|
WO2006051110A2
(en)
|
2004-11-12 |
2006-05-18 |
Novo Nordisk A/S |
Stable formulations of insulinoptropic peptides
|
|
AU2005307797B2
(en)
|
2004-11-16 |
2011-06-02 |
Alkermes Pharma Ireland Limited |
Injectable nanoparticulate olanzapine formulations
|
|
JP5107725B2
(ja)
*
|
2005-01-14 |
2012-12-26 |
カムルス エービー |
ＧｎＲＨ類似体製剤
|
|
JP2008530134A
(ja)
|
2005-02-15 |
2008-08-07 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子ベンゾジアゼピンのエアロゾル製剤および注射用製剤
|
|
KR20070120970A
(ko)
|
2005-02-23 |
2007-12-26 |
유에이비 리서치 파운데이션 |
알킬-글리코시드로 증진된 예방접종
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
WO2007002465A2
(en)
|
2005-06-23 |
2007-01-04 |
Rapid Pharmaceuticals, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
ATE544444T1
(de)
*
|
2005-10-11 |
2012-02-15 |
Yissum Res Dev Co |
Zusammensetzungen für die nasale abgabe
|
|
US8911751B2
(en)
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
|
JP2009515895A
(ja)
|
2005-11-14 |
2009-04-16 |
ピーター ディー． ウインチ |
注射用薬物および薬学的に許容されるその塩の着色溶液
|
|
DE102006027795A1
(de)
*
|
2006-06-16 |
2007-12-20 |
Lts Lohmann Therapie-Systeme Ag |
Raucherentwöhnungs-Kombinationswafer
|
|
US7425542B2
(en)
*
|
2006-06-23 |
2008-09-16 |
Aegis Therapeutics, Inc. |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US20090326193A1
(en)
|
2006-06-23 |
2009-12-31 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US7998927B2
(en)
|
2006-06-23 |
2011-08-16 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US8084022B2
(en)
|
2006-06-23 |
2011-12-27 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
TW200824693A
(en)
*
|
2006-08-28 |
2008-06-16 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of clonazepam and methods of use thereof
|
|
US20080275030A1
(en)
|
2007-01-19 |
2008-11-06 |
Sveinbjorn Gizurarson |
Methods and Compositions for the Delivery of a Therapeutic Agent
|
|
IL181217A0
(en)
*
|
2007-02-08 |
2007-07-04 |
Haim Levy |
Pharmaceuticalcompositions based on a microemulsion
|
|
US8530463B2
(en)
*
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
CA2723470C
(en)
|
2007-05-07 |
2013-12-03 |
Hale Biopharma Ventures, Llc |
Nasal administration of benzodiazepines
|
|
US20090004281A1
(en)
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
US20110038899A1
(en)
|
2008-03-28 |
2011-02-17 |
Garry Thomas Gwozdz |
Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents
|
|
JP5613657B2
(ja)
|
2008-03-28 |
2014-10-29 |
ヘイル バイオファーマ ベンチャーズ，エルエルシー |
ベンゾジアゼピン組成物の投与
|
|
KR101517415B1
(ko)
*
|
2008-05-14 |
2015-05-07 |
에스케이바이오팜 주식회사 |
난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
|
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
|
US8440631B2
(en)
|
2008-12-22 |
2013-05-14 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
US20100203014A1
(en)
|
2009-02-04 |
2010-08-12 |
Aegis Therapeutics Llc |
Zwitterionic buffered acidic peptide and protein formulations
|
|
WO2012135536A1
(en)
|
2011-04-01 |
2012-10-04 |
Cpex Pharmaceuticals, Inc. |
Nasal formulations of benzodiazepine
|
|
WO2012174058A1
(en)
|
2011-06-14 |
2012-12-20 |
Crown Packaging Technology, Inc. |
Methos and system for forming high - strength beverage can ends of aluminum magnesium alloy and such can ends
|
|
EP2720699B1
(en)
|
2011-06-14 |
2018-05-16 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine
|
|
US20130224300A1
(en)
|
2011-08-26 |
2013-08-29 |
Edward T. Maggio |
Compositions and methods thereof for oral administration of drugs
|
|
WO2015095644A1
(en)
|
2013-12-20 |
2015-06-25 |
AntiOP, Inc. |
Intranasal naloxone compositions and methods of making and using same
|